Search

We're excited to announce that we've been awarded a grant from the Mozilla Foundation in partnership with Phages for Global Health (PGH), a nonprofit organization that facilitates the application of antibacterial phage technology in the dev

The Cystic Fibrosis Foundation has awarded $15 Million to 33 organizations studying how to improve outcomes for cystic fibrosis patients battling infections, and three are phage therapy-based approaches! One is for research into phages that

US phage therapy company Adaptive Phage Therapeutics has received a $9.8-million Department of Defense Award to develop phage-based vaccine candidates against SARS-CoV-2.

Dr. Saima Aslam of IPATH in San Diego received funding from the Cystic Fibrosis Foundation to initiate and maintain a multicenter clinical cohort of cystic fibrosis patients and lung transplant recipients infected with Burkholderia cepacia

Yoon Hwang of the Naval Medical Research Unit in San Antonio received the Dr. Delores M. Etter Top Scientists and Engineers of the Year Award for his research into the development of a handheld device that uses phages to detect and identify

The Academy of Finland has granted 10 million Euro for research into COVID-related projects, and part of that will fund phage work! Researchers at the University of Jyväskylä and University of Helsinki in Finland were awarded funding for a

Kevin Forsberg, a postdoctoral fellow at the Fred Hutchinson Cancer Research Center, was awarded a 1.5M NIAID New Innovators Award to pursue his research into how bacteria defend against viruses. This is the first year this award has been o

Armata Pharmaceuticals just received a $15 million award from the US Department of Defense to take its Staphylococcus aureus phage cocktail to phase 1b/2 clinical trials.

Ronen Hazan (Hebrew University of Jerusalem) and colleagues at the Hadassah Medical Center have been awarded an Israel Precision Medicine Partnership grant to pursue their phage therapy program. So far they've banked 300 phages and have tre

US biotech company Intralytix was just awarded a multimillion dollar grant from NIAID to perform a phase 1/2a clinicial trial to assess safety and efficacy of phage therapy against Shigella.

US biotech company Intralytix was just awarded a multimillion dollar grant from NIAID to perform a phase 1/2a clinicial trial to assess safety and efficacy of phage therapy against Shigella.

Researchers at Wayne State University led by Dr. Lobelia Samavati have secured a grant worth $1.98 million from the National Heart, Lung, and Blood Institute (part of the National Institutes of Health) to develop a novel T7 phage display te

Researchers at Wayne State University led by Dr. Lobelia Samavati have secured a grant worth $1.98 million from the National Heart, Lung, and Blood Institute (part of the National Institutes of Health) to develop a novel T7 phage display te